• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    CEL-SCI Corporation (CVM)

    -NYSE MKT
    1.05 Up 0.01(0.96%) Mar 31, 4:01PM EDT
    |Pre-Market : 1.06 5:56PM EDT
    Add to Portfolio
    Prev Close:1.04
    Open:1.03
    Bid:0.64 x 2000
    Ask:1.33 x 200
    1y Target Est:4.50
    Beta:-1.11
    Next Earnings Date:N/A
    Day's Range:1.02 - 1.05
    52wk Range:0.54 - 1.72
    Volume:161,237
    Avg Vol (3m):632,449
    Market Cap:96.12M
    P/E (ttm):N/A
    EPS (ttm):-0.46
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CVM

    Comparison

    Symbol% ChgMkt Cap
    CVMUp 0.96%96.12M
    CLDXUp 0.11%2.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):330.88
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-0.40
    Quarterly EPS Est (Mar-15) :-0.11
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback